Positive FAPI-PET/CT in a metastatic castration-resistant prostate cancer patient with PSMA-negative/FDG-positive disease

Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):2040-2041. doi: 10.1007/s00259-019-04623-x. Epub 2019 Dec 9.

Authors

Fadi Khreish¹, Florian Rosar¹, Clemens Kratochwil², Frederik Lars Giesel², Uwe Haberkorn^{2

3}, Samer Ezziddin⁴

Affiliations

¹ Department of Nuclear Medicine, Saarland University Hospital, Kirrberger Str., Geb. 50, D-66421, Homburg, Germany.
² Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.
³ Clinical Cooperation Unit Nuclear Medicine, DKFZ, Heidelberg, Germany.
⁴ Department of Nuclear Medicine, Saarland University Hospital, Kirrberger Str., Geb. 50, D-66421, Homburg, Germany. [email protected].

PMID: 31814067
DOI: 10.1007/s00259-019-04623-x

No abstract available

MeSH terms

Fluorodeoxyglucose F18
Heterocyclic Compounds, 1-Ring
Humans
Male
Positron Emission Tomography Computed Tomography*
Prostatic Neoplasms, Castration-Resistant* / diagnostic imaging

Substances

Heterocyclic Compounds, 1-Ring
Fluorodeoxyglucose F18